These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10847768)

  • 1. Influence of host and parasite factors on the innate immune response and Th2 stability following infection with Leishmania major.
    Hondowicz B; Scott P
    Microbes Infect; 1999 Jan; 1(1):65-71. PubMed ID: 10847768
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulatory T cells: mediating compromises between host and parasite.
    Sakaguchi S
    Nat Immunol; 2003 Jan; 4(1):10-1. PubMed ID: 12496970
    [No Abstract]   [Full Text] [Related]  

  • 3. [LACK protein of Leishmania major: a pivotal antigen in the immune relation between host and parasite].
    Gangneux JP
    Sante; 1997; 7(6):425. PubMed ID: 9503502
    [No Abstract]   [Full Text] [Related]  

  • 4. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite.
    Menon JN; Bretscher PA
    Eur J Immunol; 1998 Dec; 28(12):4020-8. PubMed ID: 9862338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response.
    Muraille E; De Trez C; Brait M; De Baetselier P; Leo O; Carlier Y
    J Immunol; 2003 Apr; 170(8):4237-41. PubMed ID: 12682257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In cutaneous leishmaniasis, induction of retinoic acid in skin-derived Langerhans cells is not sufficient for induction of parasite persistence-mediating regulatory T cells.
    Dietze-Schwonberg K; Kautz-Neu K; Lorenz B; Clausen BE; von Stebut E
    J Dermatol Sci; 2017 Sep; 87(3):307-309. PubMed ID: 28823643
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune effector mechanism in parasitic infections.
    Liew FY; Xu D; Chan WL
    Immunol Lett; 1999 Jan; 65(1-2):101-4. PubMed ID: 10065634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major.
    Tuladhar R; Oghumu S; Dong R; Peterson A; Sharpe AH; Satoskar AR
    Exp Parasitol; 2015 Jan; 148():49-55. PubMed ID: 25447125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
    Louis JA; Conceiçao-Silva F; Himmelrich H; Tacchini-Cottier F; Launois P
    Adv Exp Med Biol; 1998; 452():53-60. PubMed ID: 9889959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania susceptibility puzzle gets another twist.
    Marx J
    Science; 1996 Feb; 271(5251):912-3. PubMed ID: 8584928
    [No Abstract]   [Full Text] [Related]  

  • 13. Susceptibility to Leishmania major infection in interleukin-4-deficient mice.
    Noben-Trauth N; Kropf P; Müller I
    Science; 1996 Feb; 271(5251):987-90. PubMed ID: 8584936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/type 2 responses.
    Arendse B; Van Snick J; Brombacher F
    J Immunol; 2005 Feb; 174(4):2205-11. PubMed ID: 15699153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to Leishmania major induced by tolerance to a single antigen.
    Julia V; Rassoulzadegan M; Glaichenhaus N
    Science; 1996 Oct; 274(5286):421-3. PubMed ID: 8832890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?
    McMahon-Pratt D; Alexander J
    Immunol Rev; 2004 Oct; 201():206-24. PubMed ID: 15361243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient control of Leishmania and Strongyloides despite partial suppression of nematode-induced Th2 response in co-infected mice.
    Kolbaum J; Ritter U; Zimara N; Brewig N; Eschbach ML; Breloer M
    Parasite Immunol; 2011 Apr; 33(4):226-35. PubMed ID: 21204851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c x C57BL/6) F1 mice infected with Leishmania major.
    Nabors GS; Nolan T; Croop W; Li J; Farrell JP
    Parasite Immunol; 1995 Nov; 17(11):569-79. PubMed ID: 8817603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous recovery of pathogenicity by Leishmania major hsp100-/- alters the immune response in mice.
    Reiling L; Jacobs T; Kroemer M; Gaworski I; Graefe S; Clos J
    Infect Immun; 2006 Nov; 74(11):6027-36. PubMed ID: 17057085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host susceptibility factors to cutaneous leishmaniasis.
    Jones DE; Elloso MM; Scott P
    Front Biosci; 1998 Nov; 3():D1171-80. PubMed ID: 9820738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.